Joshua Bernstein, MD
Allergy & Immunology · Cincinnati, OHNPI 1174014955
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (56.5%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by GSK at 57.1% of the total. 2025 is the largest year on record at $13,250, 4.1 times the $3,270 reported in 2020.
Across 24 payments — averaging $737.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$10K
- Novartis$6K
- Blueprint Medicines Corporation$221
- AstraZeneca$216
- Lilly USA, LLC$133
- Sanofi US Services Inc.$125
- plus $395 from 5 others
What the payments were for
- Consulting fees$6,02034%
- Speaking & faculty fees$10,00056%
- Travel & lodging$3562%
- Food & beverage$1,3267%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 3 | $10,112 |
| Novartis | 8 | $6,500 |
| Blueprint Medicines Corporation | 2 | $221 |
| AstraZeneca | 2 | $216 |
| Lilly USA, LLC | 2 | $133 |
| Sanofi US Services Inc. | 1 | $125 |
| Genentech USA, Inc. | 1 | $122 |
| Regeneron Healthcare Solutions, Inc. | 1 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $103 |
| Biocryst Pharmaceuticals, Inc. | 1 | $30 |
| GC Biopharma USA, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,702 in reported general payments places this provider in the 80th percentile of 128 allergy & immunology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 55 | $1,212 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 14 | $856 |
| Fluticasone Propionate | 22 | $313 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Cincinnati
- Justin GreiweCincinnati$1M
- Jonathan BernsteinCincinnati$810K
- Gordon MyersCincinnati$346K
- David BernsteinCincinnati$93K
- Sheharyar DurraniCincinnati$87K
- David TapkeCincinnati$17K
- Jeffrey RaubCincinnati$14K
- Juan AboniaCincinnati$12K
- John SeyerleCincinnati$8K
- Heather HartmanCincinnati$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.